Fiduciary Trust Co Has $2.78 Million Holdings in Xylem Inc. (NYSE:XYL)

Fiduciary Trust Co lifted its stake in shares of Xylem Inc. (NYSE:XYLFree Report) by 4.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,594 shares of the industrial products company’s stock after buying an additional 879 shares during the period. Fiduciary Trust Co’s holdings in Xylem were worth $2,781,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Xylem by 3.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 606,168 shares of the industrial products company’s stock worth $81,851,000 after purchasing an additional 18,347 shares during the last quarter. Providence Capital Advisors LLC grew its stake in shares of Xylem by 1.1% in the third quarter. Providence Capital Advisors LLC now owns 46,909 shares of the industrial products company’s stock worth $6,334,000 after purchasing an additional 531 shares during the last quarter. FORA Capital LLC bought a new stake in shares of Xylem in the third quarter worth $2,194,000. Blueshift Asset Management LLC bought a new stake in shares of Xylem in the third quarter worth $365,000. Finally, Glenmede Trust Co. NA grew its stake in shares of Xylem by 3.4% in the third quarter. Glenmede Trust Co. NA now owns 18,399 shares of the industrial products company’s stock worth $2,484,000 after purchasing an additional 605 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Trading Up 0.9 %

XYL opened at $125.61 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.96 and a quick ratio of 1.42. Xylem Inc. has a fifty-two week low of $102.63 and a fifty-two week high of $146.08. The firm has a market capitalization of $30.52 billion, a PE ratio of 36.73, a P/E/G ratio of 2.31 and a beta of 1.05. The company’s 50-day moving average is $129.75 and its 200 day moving average is $133.94.

Xylem (NYSE:XYLGet Free Report) last posted its earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.11. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The company had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.17 billion. During the same quarter in the prior year, the business posted $0.99 EPS. The firm’s revenue was up .2% compared to the same quarter last year. As a group, research analysts predict that Xylem Inc. will post 4.23 earnings per share for the current fiscal year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, November 26th. This represents a $1.44 annualized dividend and a yield of 1.15%. Xylem’s dividend payout ratio (DPR) is 42.11%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Robert W. Baird reduced their price objective on shares of Xylem from $175.00 to $154.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Royal Bank of Canada reduced their price objective on shares of Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. UBS Group assumed coverage on shares of Xylem in a research report on Tuesday, August 13th. They set a “buy” rating and a $165.00 price target on the stock. Finally, TD Cowen dropped their price objective on shares of Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a report on Wednesday, November 6th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $149.64.

View Our Latest Report on XYL

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.